GSK teams up with Siemens
18 Sep 2015
Siemens has signed a global deal with GlaxoSmithKline (GSK) to supply automation equipment and services to its production and R&D sites.
The deal was announced as GSK looks to simplify and standardise its automation suppliers.
The partnership will focus on GSK’s process control, equipment control and building management systems within the manufacturing and R&D operations.
Four key areas of focus have been identified by GSK as modular manufacturing, batch sterile facility blue print, machine and production line optimisation, and manufacturing blue print for different dosage forms.
“One of our objectives is to simplify and standardise the automation space by identifying a small number of systems and suppliers and this is the first step on our journey to achieving this,” said Dave Tudor, vice president primary supply and leader of the global automation steering team of GSK.
Integrated automation solutions are becoming important levers for pharmaceutical companies seeking to raise efficiency and productivity without sacrificing safety and quality, said Eckard Eberle, chief executive of the Siemens Business Unit Process Automation.
“As a reliable partner we will support GSK on this way by providing a unique integrated portfolio comprising hardware, software and services across the entire plant life cycle.”
